On Wednesday, October 10th, Stiles Eyecare Excellence (SEE) performed its first two successful Hydrus implant surgeries, less than two months after the FDA approved commercial use of the Hydrus Microstent. This achievement made SEE the first practice in Kansas City to successfully complete the Hydrus implant procedure.
The purpose of the Hydrus Microstent surgery is to relieve high intraocular pressure (IOP) in patients with primary open angle glaucoma (POAG). During this procedure, the Microstent is carefully inserted into the primary fluid canal, using the same incisions from cataract surgery. The device creates a channel and an unobstructed path for the eye’s fluid to flow freely again.
On the back of these successful cases, we are thrilled to provide the Hydrus Microstent as an option for POAG patients in the days to come.